Drug Discovery World wants to know and has asked the Pistoia Alliance to submit an article next month on this subject. And while we have some ideas already, we’d love to open this question to the floor. What do you see as the obstacles to innovation in the pharmaceutical industry?
We’d prefer for the moment to hold our own thoughts close to our chests and instead ask how you’d characterize these barriers. Are they primarily to do with process and technology? Or is it institutionalized bureaucracy? Perhaps a combination of factors? We hope we can get a lively conversation going in the comments. Please invite your colleagues and peers to participate in the dialogue.